Literature DB >> 26454533

[Epiretinal membranes].

B Dupas1, R Tadayoni2, A Gaudric2.   

Abstract

Idiopathic epiretinal membranes represent a common condition, and are present in approximately 10% of people over the age of 70 years. They are idiopathic in 80% of cases, or may be secondary to various conditions such as a prior retinal detachment, or vascular or inflammatory retinal diseases. The main symptoms are visual loss and metamorphopsia. The diagnosis of epiretinal membrane is currently facilitated by OCT, which provides prognostic and therapeutic decision-making assistance. Surgery for epiretinal membranes is currently well codified through sutureless vitrectomy and dyes. Dissection of the membrane (with or without associated peeling of the internal limiting membrane) ensures good anatomical and functional results, while being relatively minimally invasive.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Colorant; Internal limiting membrane; Limitante interne; Macula; Macular pucker; Membrane; Pseudo-trou; Pseudohole; Retina; Rétine; Vitrectomie; Vitrectomy

Mesh:

Year:  2015        PMID: 26454533     DOI: 10.1016/j.jfo.2015.08.004

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  3 in total

1.  Macular microvasculature features before and after vitrectomy in idiopathic macular epiretinal membrane: an OCT angiography analysis.

Authors:  Hui Chen; Wei Chi; Xiaojuan Cai; Yang Deng; Xintong Jiang; Yantao Wei; Shaochong Zhang
Journal:  Eye (Lond)       Date:  2018-11-22       Impact factor: 3.775

2.  Anatomic and functional results of idiopathic macular epiretinal membrane surgery.

Authors:  Mehmet Ozgur Cubuk; Erkan Unsal
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

3.  The outcomes of epiretinal membrane peeling in patients with foveal herniation.

Authors:  Abdullah Ozkaya; Gurkan Erdogan; Gokhan Demir
Journal:  Int J Retina Vitreous       Date:  2018-11-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.